JP2008500363A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500363A5
JP2008500363A5 JP2007515318A JP2007515318A JP2008500363A5 JP 2008500363 A5 JP2008500363 A5 JP 2008500363A5 JP 2007515318 A JP2007515318 A JP 2007515318A JP 2007515318 A JP2007515318 A JP 2007515318A JP 2008500363 A5 JP2008500363 A5 JP 2008500363A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
alkyl
alkylaryl
arylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007515318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500363A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/018443 external-priority patent/WO2005117590A2/en
Publication of JP2008500363A publication Critical patent/JP2008500363A/ja
Publication of JP2008500363A5 publication Critical patent/JP2008500363A5/ja
Pending legal-status Critical Current

Links

JP2007515318A 2004-05-26 2005-05-25 新規化合物、該化合物を含む医薬組成物、および該化合物の使用方法 Pending JP2008500363A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57463904P 2004-05-26 2004-05-26
PCT/US2005/018443 WO2005117590A2 (en) 2004-05-26 2005-05-25 Novel compounds, pharmaceutical compositions containing same, and methods of use for same

Publications (2)

Publication Number Publication Date
JP2008500363A JP2008500363A (ja) 2008-01-10
JP2008500363A5 true JP2008500363A5 (US20080131398A1-20080605-C00009.png) 2008-07-17

Family

ID=35463277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007515318A Pending JP2008500363A (ja) 2004-05-26 2005-05-25 新規化合物、該化合物を含む医薬組成物、および該化合物の使用方法

Country Status (13)

Country Link
US (1) US20090005435A1 (US20080131398A1-20080605-C00009.png)
EP (1) EP1758577A4 (US20080131398A1-20080605-C00009.png)
JP (1) JP2008500363A (US20080131398A1-20080605-C00009.png)
KR (1) KR20070095754A (US20080131398A1-20080605-C00009.png)
CN (1) CN101022792A (US20080131398A1-20080605-C00009.png)
AU (1) AU2005249437A1 (US20080131398A1-20080605-C00009.png)
BR (1) BRPI0510397A (US20080131398A1-20080605-C00009.png)
CA (1) CA2568639A1 (US20080131398A1-20080605-C00009.png)
IL (1) IL179530A0 (US20080131398A1-20080605-C00009.png)
MX (1) MXPA06013687A (US20080131398A1-20080605-C00009.png)
RU (1) RU2006146051A (US20080131398A1-20080605-C00009.png)
WO (1) WO2005117590A2 (US20080131398A1-20080605-C00009.png)
ZA (1) ZA200700024B (US20080131398A1-20080605-C00009.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014248A2 (en) * 2005-07-26 2007-02-01 Johns Hopkins University Method of reducing food intake
EP2946778A1 (en) * 2006-09-22 2015-11-25 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
US8912177B2 (en) * 2007-10-05 2014-12-16 Genzyme Corporation Method of treating polycystic kidney diseases with ceramide derivatives
US8729239B2 (en) 2009-04-09 2014-05-20 Nuclea Biotechnologies, Inc. Antibodies against fatty acid synthase
CA2884355C (en) * 2012-09-07 2022-05-17 Janssen Pharmaceutica Nv Imidazolin-5-one derivative useful as fasn inhobitors for the treatment of cancer
CA2968288A1 (en) 2014-11-20 2016-05-26 Vib Vzw Means and methods for treatment of early-onset parkinson's disease
CN115023139A (zh) 2020-01-23 2022-09-06 巴斯夫欧洲公司 含有醚硫酸盐的ppo配制剂
US20230397609A1 (en) 2020-10-27 2023-12-14 Basf Se Pesticide microemulsion compositions
AR124823A1 (es) 2021-02-05 2023-05-10 Basf Se Composiciones herbicidas líquidas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
BR0307421A (pt) * 2002-02-08 2004-12-28 Johns Kophkins University Scho Estimulação do cpt-1 como um freio para reduzir peso
CA2491802C (en) * 2002-07-09 2012-04-10 Fasgen, Inc. Novel compounds, pharmaceutical compositions containing same, and methods of use for same

Similar Documents

Publication Publication Date Title
JP2008500363A5 (US20080131398A1-20080605-C00009.png)
JP2005533835A5 (US20080131398A1-20080605-C00009.png)
JP2008511601A5 (US20080131398A1-20080605-C00009.png)
JP2008505157A5 (US20080131398A1-20080605-C00009.png)
JP2009536660A5 (US20080131398A1-20080605-C00009.png)
JP2010515731A5 (US20080131398A1-20080605-C00009.png)
JP2007511546A5 (US20080131398A1-20080605-C00009.png)
JP2008510770A5 (US20080131398A1-20080605-C00009.png)
JP2018135343A5 (US20080131398A1-20080605-C00009.png)
JP2009525302A5 (US20080131398A1-20080605-C00009.png)
JP2003513015A5 (US20080131398A1-20080605-C00009.png)
JP2008535903A5 (US20080131398A1-20080605-C00009.png)
JP2010526025A5 (US20080131398A1-20080605-C00009.png)
JP2008545718A5 (US20080131398A1-20080605-C00009.png)
RU2006146051A (ru) Новые соединения, фармацевтические композиции на их основе и способы применения
JP2010519270A5 (US20080131398A1-20080605-C00009.png)
JP2013514367A5 (US20080131398A1-20080605-C00009.png)
JP2010504908A5 (US20080131398A1-20080605-C00009.png)
JP2006501201A5 (US20080131398A1-20080605-C00009.png)
JP2008515994A5 (US20080131398A1-20080605-C00009.png)
JP2002527414A5 (US20080131398A1-20080605-C00009.png)
JP2012530758A5 (US20080131398A1-20080605-C00009.png)
JP2009539943A5 (US20080131398A1-20080605-C00009.png)
JP2010534246A5 (US20080131398A1-20080605-C00009.png)
JP2007502817A5 (US20080131398A1-20080605-C00009.png)